Table 5.
Control group | Patients undergoing KT | p | |
---|---|---|---|
Age | N=395 | N=149 | |
18 to 30 years | 68 (17) | 29 (19) | 0.078 |
31 to 50 years | 210 (53) | 71 (48) | |
51 to 65 years | 97 (25) | 46 (31) | |
More than 65 years | 20 (5) | 3 (2) | |
Gender | N=398 | N=149 | |
Female | 333 (84) | 84 (56) | <0.001 |
Male | 65 (16) | 65 (44) | |
Race | N=385 | N=149 | |
White | 269 (68) | 102 (68) | 0.151 |
Non-white | 116 (29) | 47 (32) | |
N=348 | N=149 | ||
BMI (kg/m2) | 25.9 ± 4.9 | 25.4 ± 5.3 | 0.118 |
25.2 (16.8 - 56.3) | 24.9 (16.4 - 44.0) | ||
N=382 | N=145 | ||
Creatinine (mg/dL) | 0.8 ± 0.1 | 1.8 ± 0.7 | <0.001 |
0.8 (0.4 - 1.2) | 1.5 (0.6 - 4.5) | ||
N=384 | N=144 | ||
Albumin (g/dL) | 4.5 ± 0.3 | 4.4 ± 0.4 | <0.001 |
4.5 (3.3 - 5.4) | 4.4 (3.4 - 5.5) | ||
N=382 | N=142 | ||
Ca (mg/dL) | 9.6 ± 0.5 | 8.9 ± 0.6 | <0.001 |
9.6 (6.7 - 10.8) | 8.9 (7.0 - 10.2) | ||
N=383 | N=147 | ||
P (mg/dL) | 3.8 ± 0.7 | 3.0 ± 0.8 | <0.001 |
3.8 (1.8 - 7.6) | 2.9 (1.2 - 5.4) | ||
N=352 | N=148 | ||
PTHi (pg/dL) | 64.9 ± 24.8 | 80.1 ± 78.3 | <0.001 |
60.5 (5.0 - 144.0) | 53.9 (9.5 - 562.5) | ||
N=398 | N=149 | ||
25(OH)D (ng/mL) | 23.8 ± 10.4 | 21.8 ± 12.8 | 0.056 |
21.6 (6.0 - 64.3) | 20.7 (4.0 - 70.5) | ||
N=381 | N=145 | ||
ALP (U/L) | 70.9 ± 26.1 | 74.4 ± 40.1 | 0.306 |
69.0 (24.0 - 369.0) | 65.8 (29.7 - 364.5) |
Values are expressed as number of patients (%), mean±SD and median (range). KT: kidney transplant; BMI: body mass index; Ca: calcium; P: phosphorus; PTHi: intact parathyroid hormone; 25(OH)D: 25 hydroxyvitamin D; ALP: alkaline phosphatase.